Biohaven Pharmaceutical Holding Company Ltd. Increase (Decrease) in Accrued Liabilities
Biohaven Pharmaceutical Holding Company Ltd. reported Increase (Decrease) in Accrued Liabilities of $63.87 million for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2021-08-09
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for the quarter ending 2021-06-30 was $3.20M, a 91.72% decline year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for the quarter ending 2021-03-31 was $60.67M, a 2021.19% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for the quarter ending 2020-12-31 was $26.67M, a 62.04% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for the quarter ending 2020-09-30 was $23.87M, a 433.10% increase year-over-year.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for fiscal 2020 was $92.08M, a 112.56% increase from fiscal 2019.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for fiscal 2019 was $43.32M, a 1071.76% increase from fiscal 2018.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for fiscal 2018 was $3.70M, a 175.69% increase from fiscal 2017.
- Biohaven Pharmaceutical Holding Company Ltd. increase (decrease) in accrued liabilities for fiscal 2017 was $1.34M, a 37.57% decline from fiscal 2016.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2021-06-30 | $3.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $63.87M 10-Q · filed 2021-08-09 | $90.54M derived: sum of 3 quarters · filed 2021-08-09 | $114.40M derived: sum of 4 quarters · filed 2021-08-09 |
| 2021-03-31 | $60.67M 10-Q · filed 2021-05-10 | $87.33M derived: sum of 2 quarters · filed 2021-05-10 | $111.20M derived: sum of 3 quarters · filed 2021-05-10 | $149.88M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-12-31 | $26.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $50.54M derived: sum of 2 quarters · filed 2021-03-01 | $89.22M derived: sum of 3 quarters · filed 2021-08-09 | $92.08M 10-K · filed 2021-03-01 |
| 2020-09-30 | $23.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $62.55M derived: sum of 2 quarters · filed 2021-08-09 | $65.41M 10-Q · filed 2020-11-09 | $81.87M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-06-30 | $38.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $41.54M 10-Q · filed 2021-08-09 | $58.00M derived: sum of 3 quarters · filed 2021-08-09 | $62.48M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $2.86M 10-Q · filed 2021-05-10 | $19.32M derived: sum of 2 quarters · filed 2021-05-10 | $23.80M derived: sum of 3 quarters · filed 2021-05-10 | $39.48M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $16.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $20.93M derived: sum of 2 quarters · filed 2021-03-01 | $36.62M derived: sum of 3 quarters · filed 2021-03-01 | $43.32M 10-K · filed 2021-03-01 |
| 2019-09-30 | $4.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $20.16M derived: sum of 2 quarters · filed 2020-11-09 | $26.86M 10-Q · filed 2020-11-09 | $25.04M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $15.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $22.39M 10-Q · filed 2020-08-10 | $20.56M derived: sum of 3 quarters · filed 2021-03-01 | $22.44M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $6.70M 10-Q · filed 2020-05-07 | $4.88M derived: sum of 2 quarters · filed 2021-03-01 | $6.75M derived: sum of 3 quarters · filed 2021-03-01 | $10.43M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $54.00K derived: sum of 2 quarters · filed 2021-03-01 | $3.72M derived: sum of 3 quarters · filed 2021-03-01 | $3.70M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $5.55M derived: sum of 2 quarters · filed 2019-11-01 | $5.52M 10-Q · filed 2019-11-01 | -$3.51M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $3.64M 10-Q · filed 2019-08-09 | -$5.39M derived: sum of 3 quarters · filed 2020-02-26 | $1.29M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | -$27.00K 10-Q · filed 2019-05-08 | -$9.06M derived: sum of 2 quarters · filed 2020-02-26 | -$2.38M derived: sum of 3 quarters · filed 2020-02-26 | -$1.68M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | -$9.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$2.36M derived: sum of 2 quarters · filed 2020-02-26 | -$1.65M derived: sum of 3 quarters · filed 2020-02-26 | $1.34M 10-K · filed 2020-02-26 |
| 2017-09-30 | $6.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $7.38M derived: sum of 2 quarters · filed 2018-11-14 | $10.37M 10-Q · filed 2018-11-14 | $6.09M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $706.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $3.70M 10-Q · filed 2018-08-14 | -$581.00K derived: sum of 3 quarters · filed 2019-02-28 | $3.72M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $2.99M 10-Q · filed 2018-05-15 | -$1.29M derived: sum of 2 quarters · filed 2019-02-28 | $3.02M derived: sum of 3 quarters · filed 2019-02-28 | $4.58M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | -$4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $24.00K derived: sum of 2 quarters · filed 2019-02-28 | $1.59M derived: sum of 3 quarters · filed 2019-02-28 | $2.15M 10-K · filed 2019-02-28 |
| 2016-09-30 | $4.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $5.86M derived: sum of 2 quarters · filed 2017-11-14 | $6.43M 10-Q · filed 2017-11-14 | |
| 2016-06-30 | $1.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $2.12M 10-Q · filed 2017-08-14 | ||
| 2016-03-31 | $562.00K 10-Q · filed 2017-06-16 | |||
| 2015-12-31 | $132.00K 10-K · filed 2018-03-06 |